If you need more lookups,
subscriptions start at $34 USD/month.
Mark Fitzgerald Location
Boston, MA, US
Mark Fitzgerald Work
Director of Chemistry @ (October 2024 - Present)
Chemistry Consultant @ (June 2024 - September 2024)
Director of Chemistry @ (December 2021 - June 2024)
Associate Director of Chemistry @ (January 2020 - November 2021)
Senior Research Chemist II @ (April 2016 - December 2019)
Senior Research Chemist I @ (January 2014 - April 2016)
Research Chemist II @ (July 2012 - January 2014)
Research Investigator @ Pamlico Pharmaceutical Inc (August 2011 - February 2012)
Research Chemist II @ (January 2011 - July 2011)
Research Chemist I @ (November 2008 - December 2010)
Graduate Student @ The University of Pennsylvania Department of Chemistry (August 2003 - October 2008)
Reseach Associate @ 3-Dimensional Pharmaceuticals (April 2001 - July 2003)
Research Associate @ Provid Research, division of Praecis Pharmaceuticals (June 1999 - March 2001)
Undergraduate Research Assistant @ Rutgers University, Department of Chemistry (January 1997 - August 1999)
Mark Fitzgerald Education
Rutgers University
B.A. (Chemistry)
University of Pennsylvania
PhD (Organic Chemistry)
Mark Fitzgerald Skills
ADME
Building Internal & External Relationships
Communication
Drug Discovery
HPLC
Library Design
Medicinal Chemistry
NMR
Organic Synthesis
Parallel Synthesis
Presentations
Project Leadership
Structure Based Drug Design
Targeted Protein Degradation
Waste Disposal
Mark Fitzgerald Summary
Mark Fitzgerald, based in Boston, MA, US, is currently a Director of Chemistry at Superluminal Medicines Inc.. Mark Fitzgerald brings experience from previous roles at Nested Therapeutics and C4 Therapeutics, Inc.. Mark Fitzgerald holds a B.A. in Chemistry @ Rutgers University. With a robust skill set that includes ADME, Building Internal & External Relationships, Communication, Drug Discovery, HPLC and more. Mark Fitzgerald has 5 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Mark Fitzgerald?
Find contact details for 700 million professionals.